HCEMM logo
SCIENCE_CAFE_LOGO_White
embl-european-molecular-biology-laboratory-logo
HCEMM logo
SCIENCE_CAFE_LOGO_White
embl-european-molecular-biology-laboratory-logo

Presentations, Posters and Conference talks

Immuno-inflammatory Diseases

Edit Buzás, HCEMM-SU Extracellular Vesicles Research Group

  • Edit Buzás: Microvesicles in health and disease..
    „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, dec. 2021.
  • Xabier Osteikoetxea: Engineered Cas9 extracellular vesicles as a novel gene editing tool.
    ISEV2022, Lyon, France, may. 2022.
  • Edit Buzás: Contamination of extracellular vesicle preparations or biomolecular corona around around extracellular vesicles?.
    1st Meeting of the Portugese Network on Extracellular Vesicles, Porto, Portugal, sep. 2021.
  • Edit Buzás: Interactions of the extracellular vesicle surface.
    2nd EVITA Symposium, Ciocco, Italy, sep. 2021.
  • Edit Buzás: Extracellular vesicles: lessons in vitro, ex vivo and in vivo.
    ISCTICO-HUPHAR-IUPHAR international conference, Pécs, Hungary, okt. 2021.
  • Brachyahu Meir Kestecher: EV-LDL Association – Finding A Link to Atherosclerosis.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, nov. 2021.
  • Edit Buzás: Overview and Background on Extracellular vesicles.
    2nd Lugano Exo Day, Lugano, Switzerland, apr. 2022.
  • Edit Buzás: Paradigm shifts in extracellular vesicle biology.
    CNR-EV-NET first workshop, Rome, Italy, apr. 2022.
  • Edit Buzás: Extracellular vesicle trafficking.
    About Frontiers in CardioVascular Biology (FCVB) , Budapest, Hungary, apr. 2022.

Prof. András Dinnyés, HCEMM-USZ StemCell Research Group

  • András Dinnyés: .
    Interjú Dinnyés Andrással a Kossuth Rádió, “Napközben” c. műsorában, Hungary, jan. 2021.
  • András Dinnyés: .
    Kerekasztal beszelgetes Dinnyés Andrással a CEU “Határtalan Tudás” c. rendezvényén, Hungary, feb. 2021.
  • András Dinnyés: Van, aki még a vakcinákat is elutasítja, nemhogy egy sertésszívet.
    Qubit online cikkben interjú, Hungary, feb. 2021.
  • András Dinnyés: Génszerkeszett babák? Megszűnő betegségek? Örök élet? – bioetikai kérdések és válaszok.
    Online Cikk. Szeretlek Magyarország, Dinnyés András nyilatkozatával , Hungary, feb. 2021.
  • András Dinnyés: .
    Interjú Dr. Dinnyés Andrással a Klubrádió “Utópia” c. Műsorában, Hungary, mar. 2021.
  • András Dinnyés: .
    Interjú Dr. Dinnyés Andrással a Magyar Katolikus Rádió “A héten történt – Előtérben a háttér” c. műsorában, Hungary, mar. 2021.
  • András Dinnyés: .
    Interjú Dr. Dinnyés Andrással a Kossuth Rádió “Felfedező” c. műsorában, Hungary, apr. 2021.
  • András Dinnyés: New approach methods (NAMs) for developmental neurotoxicology using human iPSC-derived 2D and 3D neuronal models. .
    Advanced Organotypic Models for Toxicological Screening, , may. 2021.
  • András Dinnyés: Dolly, a ballerina.
    Online cikkben interjú: Magyar Nemzet (Lugas rovat) , Hungary, jul. 2021.
  • András Dinnyés: .
    Interjú Dr. Dinnyés Andrással a Laikus TV “Kódolatlan” c. műsorában, Hungary, jul. 2021.
  • András Dinnyés: Regenerative medicine solutions for type 1 diabetes: The iNanoBit project.
    BIOCEV Regeneration 1Vestec, Vestec, Czech Republic, sep. 2021.
  • András Dinnyés: .
    Interjú Dr. Dinnyés Andrással a HírTV “Radar” c. műsorában, Hungary, sep. 2021.
  • András Dinnyés: Stem cell biology in basic research and diseases.
    „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, okt. 2021.
  • András Dinnyés: Modelling Alzheimer’s disease pathology through multilineage differentiation of disease-specific human induced pluripotent stem cells.
    EMBO Workshop: Microglia 2021, Heidelberg, Germany, okt. 2021.
  • András Dinnyés: Mesterségesen létrehozott szövetek és szervek őssejtekből- A regenerációs orvoslás lehetőségei.
    Előadás. Civil Közösségi Ház , Gödöllő, Hungary, nov. 2021.
  • András Dinnyés: .
    Interjú Dr. Dinnyés Andrással a HiScool Alapítvány által szervezett pályaorientációs nap alkalmából, Hungary, dec. 2021.
  • András Dinnyés: .
    Dr. Dinnyés András előadása az ELTE Radnóti Miklós Gyakorlóiskola X Hischool Pályaválasztási Fesztiválon, Hungary, jan. 2022.
  • András Dinnyés: A meghalt kutyákat már több helyen klónozzák – De milyen lesz a másolat házikedvenc?.
    Tudás.hu online cikkben interjú , Hungary, jan. 2022.
  • András Dinnyés: Sertésszív ültetése emberbe, xenotranszplantáció.
    Interjú Dr. Dinnyés Andrással a Kossuth Rádió “Felfedező” c. műsorában, Hungary, jan. 2022.
  • András Dinnyés: .
    Interjú Dr. Dinnyés Andrással a Heti TV “Heti Jégbüfé” c. műsorában, Hungary, feb. 2022.
  • András Dinnyés: Disznószív átültetés emberbe. Kutatás az “örök fiatalságért”.
    Interjú Dr. Dinnyés Andrással a Magyar Katolikus Rádió “Kerengő” c. műsorában, Hungary, apr. 2022.
  • András Dinnyés: Genetikailag újraprogramozott őssejtek felhasználása a regenerációs medicina területén.
    Project Management Institute Budapest, Hungarian Chapter “Lunch & Learn Webinar” c. rendezvényén, Hungary, may. 2022.
  • András Dinnyés: Alzheimer disease modelling by hiPSC-derived neurons and microglia like cells.
    International Neuroscience Meeting, Budapest 2022 – IBRO Workshop, Budapest, Hungary, jan. 2022.
  • András Dinnyés: The impact of environmental exposures on the neuronal differentiation of pluripotent stem cells.
    International Neuroscience Meeting, Budapest 2022 – IBRO Workshop, Budapest, Hungary, jan. 2022.
  • András Dinnyés: In vitro neurotoxicological studies using hiPSCs and SH-SY5Y cells.
    International Neuroscience Meeting, Budapest 2022 – IBRO Workshop, Budapest, Hungary, jan. 2022.
  • András Dinnyés: New approach methods (NAMs) for developmental neurotoxicology using human iPSC-derived 2D and 3D neuronal models.
    Webinar Series: “Advanced Organotypic Models for Toxicological Screening”, , apr. 2021.
  • András Dinnyés: Humán pluripotens őssejt technológiai platform a betegségmodellezés és a regenerációs medicina területén.
    Magyar Személyre Szabott Medicina Társaság XI. konferenciája, Mátrafüred, Hungary, aug. 2021.
  • Viktória Király: In vitro neurotoxicological studies using differentiated SH-SY5Y cells.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, nov. 2021.

Balázs Enyedi, HCEMM-SU Inflammatory Signaling Research Group

  • Balázs Enyedi: Mechanisms of tissue damage induced inflammation.
    „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, sep. 2021.
  • Balázs Enyedi : Paving the way for the live visualization of chemoattractant gradients – focusing on a novel LTB4 biosensor, GEM-LTB4.
    Chemotactic Cytokines Gordon Research Conference, Les Diablerets, Switzerland, jun. 2022.
  • Balázs Enyedi : The role of the nucleus in mediating tissue damage detection.
    ISCTICO-HUPHAR-IUPHAR-Joint-Conference, Pécs, Hungary, okt. 2021.
  • Szimonetta Tamás: Development of a genetically encoded LTB4 sensor.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, nov. 2021.
  • László Fazekas: Investigating tissue damage induced calcium signaling in zebrafish.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, nov. 2021.
  • Balázs Enyedi : Detecting extracellular gradients of inflammatory mediators with novel genetically encoded fluorescent biosensors.
    Straub days 2022, Szeged, Hungary, may. 2022.

Prof. Attila Gácser, HCEMM-USZ Fungal Pathogens Research Group

  • Attila Gácser: Acquired triazole resistance influences virulence properties of C. auris microevolved strains in mouse systemic infection model.
    6th Central European Forum for Microbiology, CEFORM 2021, Kecskemét, Hungary, okt. 2021.
  • Attila Gácser: Investigation of the interaction of keratinocytes and Candida species.
    6th Central European Forum for Microbiology, CEFORM 2021, Kecskemét, Hungary, okt. 2021.
  • Attila Gácser: Characterization and functional analysis of the zinc homeostasis in the human fungal pathogen C. parapsilosis.
    6th Central European Forum for Microbiology, CEFORM 2021, Kecskemét, Hungary, okt. 2021.
  • Attila Gácser: The examination of interaction between Candida species and oral pathogenic bacteria on the level of extracellular vesicles.
    6th Central European Forum for Microbiology, CEFORM 2021, Kecskemét, Hungary, okt. 2021.
  • Attila Gácser: „Tréningelt” immunmemória vizsgálata HPV-KER humán keratinocita sejteken.
    Hungarian Society for Immunology 2021. meeting, Kecskemét, Hungary, okt. 2021.
  • Attila Gácser: Candida eredetű extracelluláris vezikulumok szájüregi laphámsejtes karcinóma sejtvonalakra gyakorolt hatásának vizsgálata.
    Hungarian Society for Immunology 2021. meeting, Kecskemét, Hungary, okt. 2021.
  • Attila Gácser: Effect of Candida-derived extracellular vesicular treatment on oral squamous cell carcinoma cell lines.
    FEBS 2022 Advanced Course, Molecular Mechanisms of Host-pathogen Interactions and Virulence in Human Fungal Pathogens, La Colle sur Loup, France, may. 2022.
  • Attila Gácser: Investigation of the interaction of keratinocytes and Candida species.
    FEBS 2022 Advanced Course, Molecular Mechanisms of Host-pathogen Interactions and Virulence in Human Fungal Pathogens, La Colle sur Loup, France, may. 2022.
  • Attila Gácser: Investigation of the interaction between Candida extracellular vesicles and oral squamous cell carcinoma cell lines.
    6th Central European Forum for Microbiology, CEFORM 2021, Kecskemét, Hungary, okt. 2021.
  • Éva Veres: Investigation of the interaction between Candida extracellular vesicles and oral squamous cell carcinoma cell lines.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, nov. 2021.
  • Attila Gácser: Candida albicans enhances the development and progression of oral squamous cell carcinoma in vitro and in vivo.
    FEBS 2022 Advanced Course, Molecular Mechanisms of Host-pathogen Interactions and Virulence in Human Fungal Pathogens, La Colle sur Loup, France, may. 2022.

Prof. Lajos Kemény, HCEMM-USZ Skin Research Group

  • Máté Manczinger: Big data and personalized medicine. Drug repurposing – two for the price of one.. „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, jan. 2021.
  • Fanni Balogh: . HCEMM – PhD Symposium 2021, Siófok, Hungary, nov. 2021.
  • Lajos Kemény: Patenting or publishing?. „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, dec. 2021.
  • Dr. Beáta Szilvia Bolla: A Cutibacterium acnes hatásának vizsgálata a sebgyógyulási folyamatokra in vitro tenyésztett keratinocitákban.
    49th Annual Meeting of the Hungarian Society for Immunology, , okt. 2020.
  • Fanni Balogh: A veleszületett immunfolyamatok vizsgálata keratinocitákban.
    49th Annual Meeting of the Hungarian Society for Immunology, , okt. 2020.
  • Dr. Renáta Bozó: Cell stress-related protein expression is impaired in the uninvolved psoriatic skin.
    50th Annual ESDR Meeting, , sep. 2021.
  • Dr. Renáta Bozó: Stresszfehérjék a pikkelysömörös tünetmentes bőrsejtekben.
    49th Annual Meeting of the Hungarian Society for Immunology, , okt. 2020.
  • Prof. Dr. Zsuzsanna Bata-Csörgő: A pikkelysömör immunológiája.
    49th Annual Meeting of the Hungarian Society for Immunology, , okt. 2020.
  • Dr. Beáta Szilvia Bolla: A Cutibacterium acnes szerepének vizsgálata a sebgyógyulási folyamatokban in vitro modell rendszerekben.
    93th Annual Meeting of the Hungarian Dermatological Society, , nov. 2020.
  • Fanni Balogh: A bőr veleszületett immun memória folyamatainak vizsgálata keratinocitákban.
    93th Annual Meeting of the Hungarian Dermatological Society, , nov. 2020.
  • Dr. Renáta Bozó: Stresszfehérjék vizsgálata a pikkelysömörös tünetmentes bőrben.
    93th Annual Meeting of the Hungarian Dermatological Society, , nov. 2020.
  • Dr. Judit Danis: Az IL-23A génexpresszió szabályozásának vizsgálata keratinocitákban.
    93th Annual Meeting of the Hungarian Dermatological Society, , nov. 2020.
  • Prof. Dr. Lajos Kemény: Mesenchymal stromal cell therapy for psoriasis.
    50th Annual European Society for Dermatological Research Meeting (ESDR), , sep. 2021.
  • Prof. Dr. Zsuzsanna Bata-Csörgő: Drug induced urticaria and angioedema.
    30th EADV Congress, , sep. 2021.
  • Dr. Máté Manczinger: A mutációs szignatúrák hatása a tumorok immunogenitására.
    50th Annual Meeting of the Hungarian Society for Immunology, Kecskemét, Hungary, okt. 2021.

Bálint Kintses, HCEMM-BRC Translational Microbiology Research Group

  • Bálint Kintses: Progress report.
    Group Leader – SAP – AFC Meeting 2021, Hungary, jun. 2021.
  • Kintses Bálint: Antibiotic resistance.
    „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, sep. 2021.

József Maléth, HCEMM-USZ Molecular Gastroenterology Research Group

  • József Maléth : Translational research in gastroenterology.
    „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, okt. 2021.
  • József Maléth: CFTR activity is determined by the store-independent activation of SPCA2/STIM1/ORAI1 complex in secretory epithelial cells.
    17th ECFS (European Cystic Fibrosis Society) Basic Science Conference, Albufeira, Portugal, mar. 2022.
  • József Maléth: The inhibition of the mitochondrial Na+/Ca2+ exchanger prevents acinar cell damage in acute pancreatitis in mice.
    Magyar Gasztroenterológiai Társaság 64. Nagygyűlése, Siófok, Hungary, jun. 2022.
  • József Maléth: Characterizing 2D and 3D organoid cultures derived from mouse and human pancreas specimens.
    53rd meeting of the European Pancreatic Club, Verona, Italy, jun. 2021.
  • József Maléth: The role of Orai1 Ca2+ channel in the pancreatic ductal epithel cells under    pathophysological condition.
    European Pancreatic Club – The 53rd meeting of EPC, , jun. 2021.
  • József Maléth: Change in the expression of SerpinE1, a potential new disease activity marker, reflects therapeutic response in inflammatory bowel disease.
    16th Congress of European Crohn’s and Colitis Organisation , Virtual, jul. 2021.
  • József Maléth: Disease modelling of Inflammatory Bowel Disease by human colon organoids.
    16. European Crohn’s and Colitis Organisation, , jul. 2021.
  • József Maléth: Investigating the role of Orai1 Ca2+ channel in the progression of chronic pancreatitis.
    UEG (United European Gastroenterology) Week, -, okt. 2021.
  • József Maléth: The role of Orai1 Ca2+ channel in the pancreatic ductal epithelial cells under pathophysological conditions.
    UEG (United European Gastroenterology) Week, , okt. 2021.
  • József Maléth: Characterizing 2D and 3D organoid cultures derived from mouse and human pancreatic specimens.
    APA (American Pancreatic Association) 2021 Annual Meeting, Eden Roc Miami Beach, USA, nov. 2021.
  • József Maléth: Determination of the cytokine pattern of human colon organoids derived from Inflammatory Bowel Disease patients.
    17. European Crohn’s and Colitis Organisation, , feb. 2022.
  • József Maléth: Serum and mucosal Serpin E1 concentration correlates with endoscopic activity in inflammatory bowel disease – potential new activity marker.
    17th Congress of European Crohn’s and Colitis Organisation , Virtual, feb. 2022.
  • József Maléth: Inhibition of Orai1 Ca2+ Channel has a protective role in the progression of chronic pancreatitis and rescues CFTR dysfunction in pancreatic ducts.
    European Cystic Fibrosis Society 17th ECFS Basic Science Conference, Albufeira, Portugal, mar. 2022.
  • József Maléth: Polarity-changed human pancreatic epithelial organoids provide advanced accessibility to apical membrane physiology.
    European Pancreatic Club – The 53rd meeting of EPC, , jun. 2022.
  • József Maléth: The inhibition of the mitochondrial Na+/Ca2+ exchanger prevents acinar cell damage in acute pancreatitis in mice.
    54nd Annual Meeting of EPC, , jun. 2022.
  • József Maléth: Interplay of Orai1 Ca2+ channel and Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in epithelial physiology.
    A Magyar Gasztroenerológiai Társaság 63. Nagygyűlése, , jun. 2021.
  • József Maléth: Interplay of Orai1 Ca2+ channel and Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in epithelial physiology.
    European Pancreatic Club – The 53rd meeting of EPC, , jun. 2021.
  • József Maléth: Interplay of Orai1 Ca2+ channel and Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in epithelial physiology.
    29th United European Gastroenterology Week, , okt. 2021.
  • József Maléth: Increased expression of Serpin E1, a potential new activity marker, reflects endoscopic activity and therapeutic non-response in inflammatory bowel disease.
    United European Gastroenterology Week 2021, Virtual, okt. 2021.
  • József Maléth: Interplay of Orai1 Ca2+ channel and Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in epithelial physiology.
    52nd Annual Meeting of the American Pancreas Association, Miami, USA, nov. 2021.
  • József Maléth: Characterizing 2D and 3D Organoid Cultures Derived from Mouse and Human Pancreas Specimens.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, nov. 2021.
  • Viktória Szabó: Characterizing 2D and 3D Organoid Cultures Derived from Mouse and Human Pancreas Specimens.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, nov. 2021.
  • József Maléth: Polarity-changed human pancreatic epithelial organoids provide advanced accessibility to apical membrane physiology.
    MGT-Magyar Gasztroenterológiai Társaság 64. Nagygyűlése, Siófok, Hungary, jun. 2022.
  • József Maléth: CFTR activity is determined store-independently by SCPA2/STIM1/ORAI1 complex in secretory epithelial cells.
    MGT-Magyar Gasztroenterológiai Társaság 64. Nagygyűlése, Siófok, Hungary, jun. 2022.
  • József Maléth: Serum and mucosal Serpin E1 concentration reflects to the endoscopic activity and therapy response in inflammatory bowel disease – potential new activity marker.
    Magyar Gasztroenterológiai Társaság 64. Nagygyűlése, Siófok, Hungary, jun. 2022.
  • József Maléth: CFTR activity is determined by the store-independent activation of SPCA2/STIM1/ORAI1 complex in secretory epithelial cells.
    European Pancreatic Club – The 53rd meeting of EPC, , jun. 2022.

Karolina Pircs, HCEMM-SU Neurobiology and Neurodegenerative Diseases Research Group

  • Karolina Pircs: Bőrsejtből agysejt: Sejtprogramozás alapfokon.
    Researchers Night, , nov. 2020.
  • Karolina Pircs: Direct neural conversion: New possibilities to model late onset neurodegenerative diseases.
    Biological therapies and vaccines: safety issues, physiological and immunological mechanisms (Summer School for PhD students and young researchers), , jun. 2021.
  • Karolina Pircs: Model-iN.
    Group Leader – SAP – AFC Meeting 2022, Varga tanya, Hungary, jun. 2021.
  • Karolina Pircs: How to make a great impression? Tricks and hints for the HCEMM Interview presentation.
    HCEMM Junior GL Tranining, Budapest, Hungary, sep. 2021.
  • Karolina Pircs: Model-iN.
    Inauguration Ceremony of the Incubator House, Szeged, Hungary, jan. 2022.
  • Karolina Pircs: Bőrsejtből agysejt: Sejtprogramozás alapfokon.
    Researchers Night, , mar. 2022.
  • Karolina Pircs: Direct neural conversion: New possibilities to model late onset neurodegenerative diseases.
    EMBL-HCEMM Group Leader meeting, Heidelberg, Germany, mar. 2022.
  • Veréb Zoltán: Cell-based therapies: advanced therapy medicinal products.
    „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, okt. 2021.
  • Lea Danics: RetaiN: Neuroimmunology and stress resistance _x000B_in human aging and neurodegeneration.
    IBRO22, Budapest, Hungary, jan. 2022.
  • Karolina Pircs: .
    EHDN 2021 Remote Meeting, , sep. 2021.
  • Lea Danics: RetaiN: Neuroimmunology and stress resistance _x000B_in human aging and neurodegeneration.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, nov. 2021.
  • Lea Danics: RetaiN: Neuroimmunology and stress resistance _x000B_in human aging and neurodegeneration.
    HunDoc22, Budapest, Hungary, jan. 2022.

Metabolic and Cardiovascular Diseases

László Csanády, HCEMM-SU Molecular Channelopathies Research Group

  • Márton Simon: Revealing the molecular pathophysiology of the cystic fibrosis causing mutation R117H.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, nov. 2021.

Eszter Farkas, HCEMM- USZ Cerebral Blood Flow and Metabolism Research Group

  • Eszter Farkas: Do microglia contribute to cerebral vasoregulation?.
    EMBO Workshop: Microglia 2021, Heidelberg, Germany, okt. 2021.
  • Anna Törteli: The role of spreading depolarization in the insufficiency of reperfusion after cerebrovascular occlusion.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, nov. 2021.
  • Eszter Farkas: Autoregulatory failure contributes to hypoperfusion in response to spreading depolarization.
    Experimental Biology 2022, Philadelphia, USA, apr. 2022.

Nazha Hamdani, HCEMM-SU Cardiovascular Comorbidities Research Group

Balázs Papp, HCEMM-BRC Metabolic Systems Biology Research Group

  • Roland Tengölics: Accelerated metabolome evolution of S. cerevisiae.
    Darwin Days, Tihany, Hungary, feb. 2020.
  • Eszter Ari: Evolutionary study of Hungarian coronavirus genomes.
    Tudományok Fővárosa, Budapest, Hungary, okt. 2020.
  • Eszter Ari: Evolutionary study of Hungarian coronavirus genomes.
    Researcher’s Night, Budapest, Hungary, nov. 2020.
  • Eszter Ari: Impact of restrictive measures in Hungary on the spread and genetic diversity of SARS-CoV-2 virus.
    BRC-SZAB COVID19 series of scientific lectures, , nov. 2021.
  • Eszter Ari: Phylogenetic barriers to horizontal transfer of AMP resistance genes.
    Molecular Mechanisms in Evolution (GRS), Gordon Research Seminar, Easton, USA, jun. 2019.
  • Eszter Ari: Phylogenetic barriers to horizontal transfer of AMP resistance genes.
    Molecular Mechanisms in Evolution, Gordon Research Conference, Easton, USA, jun. 2019.
  • Ádám Györkei: Disorder and surface interactions determine bacterial protein aggregation propensity in vivo.
    2019 Colorado Protein Stability Conference, Colorado, USA, jul. 2019.
  • Roland Tengölics: Rapid Non‐targeted Metabolite Profiling of Yeast.
     ICYGMB2019, Gothenburg, Sweden, aug. 2019.
  • Zsuzsa Sarkadi: Compensatory Mutations Drive Morphological  Evolution.
     ICYGMB2019, Gothenburg, Sweden, aug. 2019.
  • Balázs Szappanos: The evolution of the yeast metabolome.
    Systems Genetics: From Genomes to Complex Traits, Heidelberg, Germany, sep. 2019.
  • Gábor Grézal: Widespread regulatory rewiring upon antibiotic resistance mutations shapes cross-resistance.
    Systems Genetics: From Genomes to Complex Traits, Heidelberg, Germany, sep. 2019.
  • Orsolya Liska: Principles of Metabolome Conservation in Mammals.
    Evolutionary Systems Biology 2020, Wellcome Genome Campus conference, Hinxton, UK, feb. 2020.
  • Balázs Papp: Principles of Metabolome Conservation in Mammals.
    Evolutionary Systems Biology 2020, Wellcome Genome Campus conference, Hinxton, UK, feb. 2020.
  • Zsuzsa Sarkadi: Deleterious mutations as drivers of morphological evolution.
    Molecular Mechanisms in Evolution and Ecology – Virtual, Heidelberg, Germany, sep. 2020.
  • Roland Tengölics: Accelerated metabolome evolution in Saccharomyces cerevisiae driven by gene content changes.
    Molecular Mechanisms in Evolution and Ecology – Virtual, Heidelberg, Germany, sep. 2020.
  • Balázs Szappanos: Underground Metabolism As a Rich Reservoir for Pathway Engineering.
    7th Conference on Constraint-Based Reconstruction and Analysis (COBRA 2021), , mar. 2021.
  • Orsolya Liska: Principles of Metabolome Conservation in Mammals.
    7th Conference on Constraint-Based Reconstruction and Analysis (COBRA 2021), , mar. 2021.
  • Károly Kovács: Compensated Deleterious Mutations as Drivers of Morphological Evolution.
    Molecular Mechanisms in Evolution (GRS), Gordon Research Seminar, Easton, USA, jun. 2019.
  • Balázs Papp: Impacts of Natural Selection on the Metabolome.
    Molecular Mechanisms in Evolution, Gordon Research Conference, Easton, USA, jun. 2019.
  • Zsuzsa Sarkadi: Compensatory Mutations Drive Morphological Evolution.
    SMBE 2019, Manchester, UK, jul. 2019.
  • Károly Kovács: Compensated deleterious mutations as drivers of morphological evolution.
    23rd Evolutionary Biology Meeting at Marseilles, Marseille, France, sep. 2019.
  • Dorottya Kalapis: Unraveling the impact of compensatory evolution on metabolic divergence.
    ICSB2019, Okanawa, Japan, nov. 2019.
  • Ádám Györkei: Systematic study of Escherichia coli protein aggregation in vivo.
    Hungarian Society for Bioinformatics: Bioinformatics 2019 conference, Budapest, Hungary, nov. 2019.
  • Balázs Papp: Evolution of the metabolome in yeasts.
    Hungarian Society for Bioinformatics: Bioinformatics 2019 conference, Budapest, Hungary, nov. 2019.
  • Eszter Ari: Methods to investigate the microbiome and understand the results.
    MGT Colon Section, Visegrád, Hungary, mar. 2020.
  • Balázs Papp: Evolutionary principles of antimicrobial peptide resistance.
    10th Annual Meeting of the Nordic EMBL Partnership for Molecular Medicine, , sep. 2020.
  • Balázs Papp: Genomic epidemiology of coronavirus in Hungary.
    Epidemiology and modelling workshop, Kecskemét, Hungary, jul. 2021.
  • Balázs Papp: Principles of metabolome conservation in animals.
    Metabolic Pathway Analysis Conference, Knoxville, USA, aug. 2021.
  • Balázs Papp: Principles of metabolome conservation.
    EMBO Members Meeting 2021, Heidelberg, Germany, okt. 2021.
  • Roland Tengölics: We bring metabolite levels closer to your research – Service and research at the metabolomics lab of BRC Szeged.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, nov. 2021.
  • Eszter Ari: Timing of non-pharmaceutical interventions impacts transmission patterns across different waves of the SARS-CoV-2 pandemic: lessons from Hungary.
    HCEMM – PhD Symposium 2021, Siófok, Hungary, nov. 2021.

Zoltán Varga, HCEMM-SU Cardiometabolic Immunology Research Group

  • Tamás Gergely: Immune checkpoint inhibition with PD-1 inhibitor induces cardiac dysfunction without overt myocarditis in C57BL/6 mice.
    PhD Days 2021, Budapest, Hungary, jul. 2021.
  • Tamás Gergely: Immune checkpoint inhibition with PD-1 inhibitor induces cardiac dysfunction without overt myocarditis in C57BL/6 mice.
    ISCTICO-HUPHAR-IUPHAR international conference, Pécs, Hungary, okt. 2021.
  • Zsófia Onódi : Inflammasome activation in end-stage heart failure.
    ESCWG, Naples, Italy, may. 2019.
  • Zsófia Onódi : Inflammasome activation in end-stage heart failure.
    EMBL Meeting 2019, Barcelona, Spain, sep. 2019.
  • Zsófia Onódi : Inflammasome activation in end-stage heart failure.
    SE Symposium 2019, Budapest, Hungary, nov. 2019.
  • Imre Vörös: Investigation of cardiotoxicity by dipeptidil-peptidase-4 inhibitors on a human cardiomyocyte cell line as well as on samples from chronic heart failure patients.
    SEMMELWEIS SYMPOSIUM 2019, Budapest, Hungary, nov. 2019.
  • Zsófia Onódi : NLRP3-INDEPENDENT INFLAMMASOME ACTIVATION IN HEART FAILURE.
    PhD Days 2020, Budapest, Hungary, aug. 2020.
  • Zsófia Onódi : Transcriptomic analysis and comparative characterization of rat H9C2, human AC16 and murine HL-1 cardiac cell lines.
    PhD Days 2021, Budapest, Hungary, jul. 2021.
  • Dániel Kucsera: Characterization of the CDAA Diet-Induced Non-alcoholic Steatohepatitis Model: Sex-specific differences in Inflamma􀆟on, Fibrosis, and Cholesterol Metabolism in Middle-Aged Mice.
    PhD napok 2021, Budapest, Hungary, jul. 2021.
  • Zsófia Onódi : Transcriptomic analysis and comparative characterization of rat H9C2, human AC16 and murine HL-1 cardiac cell lines.
    ISCTICO-HUPHAR-IUPHAR international conference, Pécs, Hungary, okt. 2021.
  • Dániel Kucsera: Investigating the efficacy of anti IL 1ß monoclonal antibody treatment in an aged mouse model of non alcoholic steatohepatitis.
    ISCTICO-HUPHAR-IUPHAR international conference, Pécs, Hungary, okt. 2021.
  • Imre Vörös: Investigation of cardiotoxicity by dipeptidyl-peptidase-4 inhibitors on a human cardiomyocyte cell line as well as on samples from chronic heart failure patients.
    ISCTICO-HUPHAR-IUPHAR international conference, Pécs, Hungary, okt. 2021.
  • Dániel Kucsera: Investigating the efficacy of anti IL 1ß monoclonal antibody treatment in an aged mouse model of non alcoholic steatohepatitis.
    EPHAR 2021, Prague, dec. 2021.
  • Imre Vörös: Investigation of cardiotoxicity by dipeptidyl-peptidase-4 inhibitors on a human cardiomyocyte cell line as well as on samples from chronic heart failure patients.
    EPHAR 2021, Prague, dec. 2021.
  • Tamás Gergely: Immune checkpoint inhibition with PD-1 inhibitor induces cardiac dysfunction without overt myocarditis in C57BL/6J mice.
    FCVB 2022, Budapest, Hungary, apr. 2022.
  • Zsófia Onódi : Transcriptomic analysis and comparative characterization of rat H9C2, human AC16 and murine HL-1 cardiac cell lines.
    FCVB2022, Budapest, Hungary, apr. 2022.
  • Nabil V. Sayour: Limb remote ischemic preconditioning in rats: discrepancy between meta-analysis and a three-centre in vivo study.
    Frontiers in Cardiovascular Biomedicine, Budapest, Hungary, apr. 2022.
  • Dániel Kucsera: Evaluation of the interplay between NASH and HFpEF in varied murine age groups.
    FCVB 2022, Budapest, Hungary, apr. 2022.
  • Imre Vörös: Investigation of cardiotoxicity by dipeptidyl-peptidase-4 inhibitors in a human cardiomyocyte cell line as well as in samples from chronic heart failure patients.
    FCVB 2022, Budapest, Hungary, apr. 2022.
    • Zsófia Onódi : Inflammasome activation in end-stage heart failure.
      PhD Days 2019, Budapest, Hungary, apr. 2019.
    • Zsófia Onódi : Inflammaszóma aktiváció vizsgálata végstádiumú szívelégtelenségben.
      FAMÉ 2019, Budapest, Hungary, jun. 2019.
    • Tamás Gergely: Immune checkpoint inhibitor-induced cardiotoxicity is dependent on thymic immune response.
      2021 Congress of Hungarian Society of Cardiology, Balatonfüred, Hungary, okt. 2021.
    • Zoltán Varga: New inflammatory mechanisms in chronic heart failure.
      ISCTICO-HUPHAR-IUPHAR international conference, Pécs, Hungary, okt. 2021.
    • Nabil V. Sayour: Novel druggable targets of heart failure with reduced ejection fraction identified by droplet digital PCR and validated by Next Generation Sequencing.
      ISCTICO-HUPHAR-IUPHAR international conference, Pécs, Hungary, okt. 2021.
    • Tamás Gergely: Immune checkpoint inhibition with PD-1 inhibitor induces cardiac dysfunction without overt myocarditis in C57BL/6 mice.
      HCEMM – PhD Symposium 2021, Siófok, Hungary, nov. 2021.
    • Nabil V. Sayour: Novel druggable targets of heart failure with reduced ejection fraction identified by droplet digital PCR and validated by Next Generation Sequencing.
      HCEMM – PhD Symposium 2021, Siófok, Hungary, nov. 2021.
    • Dániel Kucsera: Investigating the efficacy of anti IL 1ß monoclonal antibody treatment in an aged mouse model of non alcoholic steatohepatitis.
      HCEMM – PhD Symposium 2021, Siófok, Hungary, nov. 2021.
    • Imre Vörös: Investigation of cardiotoxicity by dipeptidyl-peptidase-4 inhibitors in a human cardiomyocyte cell line as well as in samples from chronic heart failure patients.
      HCEMM – PhD Symposium 2021, Siófok, Hungary, nov. 2021.
    • Zoltán Varga: AIM2-driven inflammasome activation in heart failure.
      ESC Frontiers in Cardiovascular Biomedicine conference, Budapest, Hungary, apr. 2022.

    Nikolett Wohner, HCEMM-SU Thrombosis and Hemostasis Research Group

    Genomic Instability and Cancer

    Antal Berényi, HCEMM-USZ Magnetotherapeutics Research Group

    • Antal Berenyi: Transzkraniális elektromos stimuláció epilepsziában .
      Mind Clinic Seminars, Budapest, Hungary, mar. 2022.
    • Lívia Barcsai: Controlling pathologic fear expression through closed-loop brain stimulation.
      IBRO Workshop, Budapest, Hungary, jan. 2022.
    • Andrea Pejin: Closed-loop stimulation of infralimbic cortex reduces anxiety and prevents fear generalization during memory consolidation and reconsolidation.
      IBRO Workshop, Budapest, Hungary, jan. 2022.
    • Tamás Földi: TERMINATING HUMAN EPILEPTIC SEIZURES BY CLOSED-LOOP TRANSCRANIAL BRAIN STIMULATION – A FIRST-IN-PATIENT STUDY.
      IBRO Workshop, Budapest, Hungary, jan. 2022.
    • Qun Li: Reinstating olfactory bulb derived limbic gamma oscillations alleviates depression.
      IBRO Workshop, Budapest, Hungary, jan. 2022.
    • Antal Berenyi: Oscillotherapy – Closed-loop transcranial electric stimulation in epilepsy and PTSD.
      Society for Brain Mapping and Therapeutics Annual Meeting, Los Angeles, CA, USA, jul. 2021.
    • Lívia Barcsai: Electrotherapy of pathological anxiety: Modulating traumatic memories by the electrical stimulation of the brain Berényi.
      HCEMM – PhD Symposium 2021, Siófok, Hungary, nov. 2021.

    Csaba Bödör, HCEMM – SU Molecular Oncohematology Research Group

    • Csaba Bödör: Importance of molecular genetics in oncohematology.
      Scientific meeting organized by the Szeged local committee of the Hungarian Academy of Sciences, Szeged, Hunagary, mar. 2021.
    • Csaba Bödör: Molecular Diagnostics of Chronic Lymphocytic Leukemia State of the art.
      Online educational meeting, Astra-Zeneca, Online , Virtual, jan. 2022.
    • Ákos Nagy: Non-Invasive Quantitative Analysis of EZH2 Mutations in Follicular Lymphoma.
      SOHO 2021 Annual Meeting, Houston, USA, sep. 2021.
    • Lili Kotmayer: Screening for BCL2 Mutations in a Real-World Cohort of Patients with Chronic Lymphocytic Leukemia during Venetoclax Therapy.
      ESH 2nd Translational Research Conference on Chronic Lymphocytic Leukemia, Paris, France, mar. 2022.
    • Csaba Bödör: The Promise of Epigenetic Directed Therapies for the Treatment of B-Cell Malignancies.
      Annual Meeting of the European Hematology Association, Virtual, jun. 2021.
    • Csaba Bödör: State of the art molecular characterization of tumours.
      Conference of the Hungarian Society for Personalised Medicine, Mátraháza, Hungary, aug. 2021.
    • Lili Kotmayer: Germline GATA2 mutations in familial MDS/AML: a manually curated online registry from the ERAPERMED GATA2-HuMo international consortium.
      EWOG 9th International Symposium on MDS and SAA in Childhood, Athens, Greece, sep. 2021.
    • Csaba Bödör: Molecular pathogenesis and novel biomarkers in B-cell lymphomas.
      Scientific workshop: A celebration of Professor Laszlo Lajtha, Manchester, UK, okt. 2021.
    • Csaba Bödör: Molecular classification and monitoring in diffuse large B-cell lymphomas.
      Annual Meeting of the Hungarian Society for Hematology and Transfusion, Virtual, nov. 2021.
    • Ákos Nagy: Minimal invasive detection and monitoring of EZH2 mutations in follicular lymphoma.
      HCEMM – PhD Symposium 2021, Siófok, Hungary, nov. 2021.
    • Lili Kotmayer: Sensitive monitoring of therapy resistance n CLL treated with novel targeted therapies.
      HCEMM – PhD Symposium 2021, Siófok, Hungary, nov. 2021.

    Lajos Haracska, HCEMM-BRC Mutagenesis and Carcinogenesis Research Group

    • Lajos Haracska: Genomic instability and cancer.
      „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, okt. 2021.
    • Kata Dudás: The role of ZBTB1 at the stalled replication fork.
      HCEMM – PhD Symposium 2021, Siófok, Hungary, nov. 2021.
    • Nargis Karatayeva: Crosstalk between Fanconi anaemia and Rad18 DNA damage tolerance pathways.
      HCEMM – PhD Symposium 2021, Siófok, Hungary, nov. 2021.

    Tibor Pankotai, Genome Integrity and DNA Repair Core Group

    Infectious Diseases with special emphasis on Co-Morbidities

    Christoph Sensen, Circulating Nucleic Acid Biomarker Research Group

    • Christoph Sensen: Molecular markers.
      „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, okt. 2021.

    Advances Core Facilities

    Ferhan Ayaydin, HCEMM-USZ Functional Cell Biology and Immunology

    • Ferhan Ayaydin: Advanced applications of confocal laser scanning microscopy.
      Advanced fluorescence microscopy techniques in cell biology and tissue culture (As part of course series held in USZ Faculty of Science and Informatics), Szeged, Hungary, apr. 2022.
    • Ferhan Ayaydin: The Development of Imaging Setup for Whole Cell-Based Biosensor.
      FEBS Practical Course, Functional imaging of cellular dynamics, Amsterdam, The Netherlands, jun. 2022.
    • Ferhan Ayaydin: Mobile biosensor development at the FCBI Advanced Core Facility.
      FEBS Practical Course, Functional imaging of cellular dynamics, Amsterdam, The Netherlands, jun. 2022.

    Zsuzsanna Darula, HCEMM-BRC Single Cell Omics

    • Eszter Farkas: Do microglia contribute to cerebral vasoregulation? .
      EMBO Workshop: Microglia 2021, Heidelberg, Germany, okt. 2021.
    • Éva Klement: FAIMS – proteomikai alkalmazások.
      MS Szakmai Nap, , dec. 2021.
    • Zsuzsanna Darula: The Advanced Core Facility network of HCEMM.
      HCEMM inauguration ceremony, Szeged, Hungary, jan. 2022.
  • Áron Bartha: Normal and malignant kidney tissue distinction using proteome level and transcriptomic data. .
    Semmelweis Symposium, Best poster award, Budapest, Hunagry, nov. 2021.
  • Áron Bartha: Transcriptome and proteome-based study of malignant and healthy kidney tissues. .
    PhD Scientific Days 2021, Budapest, Hungary, jul. 2021.
  • Áron Bartha: A multi-omic approach to discriminate tumor and normal cells in renal clear cell carcinoma. .
    14th Annual Meeting of the Korean Society of Medical Oncology & 2021 International Conference – KSMO 2021, , sep. 2021.
  • Áron Bartha: Genes discriminating tumor and normal tissues using proteomic and transcriptomic data in renal cell carcinoma..
    European Association for Cancer Research AI in Cancer Diagnostics: from research to clinical practice, , okt. 2021.
  • Éva Klement: Ion mobility for in-depth proteomics of complex biological mixtures.
    Hungarian Molecular Life Science Conference , Eger, Hungary, nov. 2021.
  • Áron Bartha: Discriminating malignant and healthy kidney tissues using proteomic and transcriptomic data. .
    Hungarian Molecular Life Science Conference 2021, Eger, Hungary, nov. 2021.
  • Éva Klement: Quantitation using stable isotope labelled peptides to set up a diagnostic protein panel in the differentiation of renal carcinoma and normal kidney tissue.
    XIV Annual Congress of the European Proteomic Association, Leipzig, Germany, apr. 2022.
  • Ádám Pap: Analysis of urinary O-glycopeptides: Systematic evaluation of a dataset using different search engines.
    XIV Annual Congress of the European Proteomic Association, Leipzig, Germany, apr. 2022.
  • Éva Hunyadi-Gulyás: Proteomic analysis of Botrytis cinerea induced noble rot development of Furmint grape berries.
    XIV Annual Congress of the European Proteomic Association, Leipzig, Germany, apr. 2022.
  • Éva Klement: Quantitation using stable isotope labelled peptides to set up a diagnostic protein panel in the differentiation of renal carcinoma and normal kidney tissue.
    Straub days 2022, Szeged, Hungary, may. 2022.
  • Ádám Pap: Analysis of urinary O-glycopeptides: Systematic evaluation of a dataset using different search engines.
    Straub days 2022, Szeged, Hungary, may. 2022.
  • Éva Hunyadi-Gulyás: Proteomic analysis of Botrytis cinerea induced noble rot development of Furmint grape berries.
    Straub days 2022, Szeged, Hungary, may. 2022.
  • Vanda Varga-Zsíros: Investigation of tumor heterogeneity: a novel, laser microdissection-coupled lipidomic method.
    Straub days 2022, Szeged, Hungary, may. 2022.
    • Bartha Áron: Világossejtes veserák és normál vese transzkriptom és proteom szintű célzott elemzése.
      XXXIV. MOT Kongresszus, Szeged, Hungary, nov. 2021.
    • Bartha Áron: Normál és világossejtes vesedaganat proteom és transzkriptom szintű célzott elemzése. MOT Fiatal Onkológusok Szekciójának X. Konferenciája , Budapest, Hungary, sep. 2021.
    • Gábor Balogh: Development of a laser dissection-coupled quantitative microlipidomic method to resolve tumor heterogeneity. . International Conference on the Bioscience of Lipids , Utrecht, The Netherlands, okt. 2021.
    • Gábor Balogh: Egysejt lipidomika. 51. Membrán-transzport konferencia, Sümeg, Hungary, may. 2022.
    • Gyöngyi Cinege: Horizontally transferred genes are required for an effective innate immune response. Straub days 2022, Szeged, Hungary, may. 2022.

    Domokos Máthé, HCEMM-SU In Vivo Imaging

    • Domokos Máthé: Copper-64 / Actinium-225-human anti-PSCA-IgG4 theranostics of a prostate cancer model.
      Deutsche Gesellschaft für Nuklearmedizin, Hannover, Germany, apr. 2021.
    • Domokos Máthé: Prognostic significance of FDG-PET derived conventional and textural parameters in high grade B cell lymphoma.
      European Association of Nuclear Medicine and Molecular Imaging Annual Congress, Barcelona, Spain, okt. 2021.
    • Domokos Máthé : Immuno-imaging and Imaging of Fibrosis: Preparations for Post-COVID-19 Translational Results.
      Biomedical Applications in Translational Research, Karaikudi, India, may. 2020.
    • Domokos Máthé: Theranostics in Radiopharmacy: The basic research and translational perspectives gained from molecular imaging.
      International Postgraduate Conference on Radiopharmacy, Izmir, Turkey, jun. 2021.

    This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 739593. HCEMM supported by EU Programme: H2020-EU.4.a. – Teaming of excellent research institutions and low performing RDI regions. Project starting date was 1 April 2017.

    EU Flag

    Awards

    Consortium

    Semmelweis University logo
    SZTE logo
    National Research, Development and Innovation Office

    About HCEMM

    Hungarian Centre of Excellence for Molecular Medicine is a strong catalyst of reformative changes in biomedical science and in institutional research management.

    National VAT number: 26307383-2-06
    EU VAT number: HU26307383

    Linkedin Facebook Twitter Instagram
    kozadattar logo

    Internal Policies

    Contact Info

    Search
    Copyright © 2025 Hungarian Centre of Excellence for Molecular Medicine, all rights reserved. Hungarian Centre of Excellence for Molecular Medicine® and HCEMM® are registered trademarks of the the HCEMM Nonprofit Ltd.
    This website uses cookies. For more information visit the Cookies & Privacy Policy page.
    ACCEPT